review Open AccessTop 1% cited
Multi-targeted prevention of cancer by sulforaphane
Cancer Letters · 2008 · Vol. 269(2) · pp. 291–304
John Clarke(Oregon State University)Roderick H. Dashwood(Oregon State University)Emily Ho✉(Oregon State University)
Genomics, phytochemicals, and oxidative stressGlutathione Transferases and PolymorphismsSynthesis and biological activitySulforaphaneCruciferous vegetablesPhenethyl isothiocyanateCarcinogenGlucosinolateCancerIsothiocyanateCancer preventionBioavailabilityCancer research
MeSH terms
AnimalsBiological AvailabilityCell CycleHumansSulfoxidesThiocyanatesNF-kappa BAnticarcinogenic AgentsApoptosisReactive Oxygen SpeciesIsothiocyanatesMAP Kinase Signaling SystemCell ProliferationCyclin-Dependent Kinase Inhibitor p21Histone Deacetylase Inhibitors
Citations
551
FWCI
13.52
field-weighted impact
References
78
Percentile
99%
vs. same field & year
Citations per year
Cited by
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
European Journal of Medicinal Chemistry · 2014 · 426 citations
References
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Nature Reviews Drug Discovery · 2002 · 1,513 citations
Molecular basis for chemoprevention by sulforaphane: a comprehensive review
Cellular and Molecular Life Sciences · 2007 · 694 citations
Aberrant rel/nfkb genes and activity in human cancer
Oncogene · 1999 · 1,102 citations
The myrosinase‐glucosinolate system, its organisation and biochemistry
Physiologia Plantarum · 1996 · 742 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
